(Q38726443)

5 September 2017

1 reference

title

Food: The Main Course to Wellness and Illness in Patients With Irritable Bowel Syndrome (English)

1 reference

5 September 2017

William D Chey

1

1 reference

PubMed ID

26856749

5 September 2017

language of work or name

English

0 references

publication date

9 February 2016

1 reference

The American Journal of Gastroenterology

5 September 2017

1 reference

5 September 2017

111

1 reference

5 September 2017

3

1 reference

5 September 2017

366-371

1 reference

Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome

5 September 2017

1 reference

12 December 2020

Short-chain carbohydrates and functional gastrointestinal disorders.

1 reference

12 December 2020

Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome

1 reference

12 December 2020

Intestinal microbiota in functional bowel disorders: a Rome foundation report

1 reference

12 December 2020

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

1 reference

12 December 2020

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

The Science, Evidence, and Practice of Dietary Interventions in Irritable Bowel Syndrome

1 reference

12 December 2020

Food, immunity, and the microbiome.

1 reference

12 December 2020

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

1 reference

12 December 2020

Functional foods: the Food and Drug Administration perspective.

1 reference

12 December 2020

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

1 reference

12 December 2020

Food, the immune system, and the gastrointestinal tract

1 reference

12 December 2020

British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults

1 reference

12 December 2020

Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life

1 reference

12 December 2020

Food and symptom generation in functional gastrointestinal disorders: physiological aspects

1 reference

12 December 2020

Intestinal microbiota and diet in IBS: causes, consequences, or epiphenomena?

1 reference

12 December 2020

Medical foods: products for the management of chronic diseases

1 reference

12 December 2020

Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome

1 reference

12 December 2020

Eluxadoline for Irritable Bowel Syndrome with Diarrhea

1 reference

12 December 2020

Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis

1 reference

12 December 2020

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

1 reference

12 December 2020

Dietary Renaissance in IBS: Has Food Replaced Medications as a Primary Treatment Strategy?

1 reference

12 December 2020

Effect of a low-flatulogenic diet in patients with flatulence and functional digestive symptoms

1 reference

12 December 2020

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome: a clinical review.

1 reference

12 December 2020

Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI

1 reference

12 December 2020

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial

1 reference

12 December 2020

Gut microbiota as potential orchestrators of irritable bowel syndrome

1 reference

12 December 2020

Food components and irritable bowel syndrome

1 reference

12 December 2020

Functional bowel disorders

1 reference

12 December 2020

Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.

1 reference

12 December 2020

Rifaximin therapy for patients with irritable bowel syndrome without constipation

1 reference

12 December 2020

American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2016.12

1 reference

5 September 2017

1 reference

PubMed ID

26856749